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Abstract
The evidence for an enteropathogenic role of Aeromonas 
spp. is still controversial. This review examines various 
parameters related to a causative role of Aeromonas and 
concludes that infraspecific subsets of strains with a 
particular array of enterotoxin genes are potential entero-
pathogens. The consequences for stool bacteriology are 
discussed.
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Introduction
The genus Aeromonas [1] consists of facultatively anaero-
bic Gram-negative rods that are predominantly motile by 
a single polar flagellum and produce oxidase, catalase, ni-
trate reductase, and an array of exoenzymes. Most species 
are mesophilic. Members occur in water sources, soil, and 
foodstuffs. They can be agents of disease in poikilothermic 
animals (e.g., fish, reptiles) and in man.
The following infections in man have become known [2]:
(a)   wound infections or cellulites related to water or soil 
exposure;
(b)   septicemia, mainly associated with malignancies 
(particularly hematological) or hepatobiliary disease, 
rarely with diabetes mellitus or no immune defect;
(c)   localized extraintestinal infections such as meningitis, 
peritonitis, otitis media, endocarditis, osteomyelitis, 
etc.
The first case of a human Aeromonas infection reported 
was one of myositis, observed in 1954 in a woman from 
Jamaica [3]; and the first series of infections was published 
from the author’s laboratory in 1968 [4]. Since 1961, when 
the first strain was isolated from human feces [5], aeromo-
nads have been incriminated as agents of diarrhea but the 
evidence for enteropathogenicity has never been unequivo-
cal [6] because various yardsticks used to solve the question 
have proven insufficient, including Koch’s original postu-
lates and their expansion into a “unified concept” by Evans 
[7]. For the clinician, the clinical microbiology laboratory, 
and public health authorities, however, a solution would be 
of considerable importance: a positive answer would mean 
to search for aeromonads in practically every stool speci-
men by means of selective media (which are different from 
those used for other bacterial enteropathogens) [8], and to 
decide whether to treat patients with fecal aeromonads and 
whether to regularly check drinking water for the presence 
of these organisms. In fact, the US Environmental Protec-
tion Agency has already included A. hydrophila in the 
Contaminant Candidate List of organisms which require 
future regulation under the Safe Drinking Water Act [9].
The purpose of this review is to examine and interpret 
the data that have accumulated over approximately 40 years 
and to make some, albeit preliminary, recommendations 
for the clinical laboratory. Right now, most laboratories 
have their own rules regarding the isolation of aeromonads 
from stools. Aeromonas-associated diarrhea (A.-a.d.) will 
be defined as loose stools associated with the isolation of 
aeromonads in the stool.
Diarrhoic Patients vs Controls
Of the 17 phenospecies of the genus Aeromonas [1, 2], only 
four have been isolated from human feces with significant 
frequencies: A. hydrophila, A. caviae, A. veronii biovar. 
sobria (formerly “A. sobria”), and A. trota; i.e., hybridiza-
tion groups (HG) 1,4,8, and 14. The latter is a “newcomer” 
whose frequency was probably underestimated in earlier 
studies since it is susceptible to ampicillin, an agent used in 
many selective media for aeromonads [8]. A. jandaei (HG 
9) and A. schubertii (HG 12) have been rare fecal isolates 
[10]. If these species are agents of diarrhea, one should 
expect that they are more frequently present in patients 
with A.-a.d. than in controls [7]. Appropriate studies would 
have used such controls, selective media, speciation of the 
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isolates, and would have eliminated samples containing 
aeromonads together with other enteropathogens.
While not all studies have included enteropathogenic 
Escherichia coli, viruses, and parasites, results of those 
available have been contradictory. Not only did the ranking 
of aeromonads differ from first [11–13] to fifth [14] among 
enteropathogenic bacteria, but there were also differences 
in seasonal distribution and predominating species. Some 
studies observed isolation peaks in warmer seasons [12, 13, 
15], others saw no seasonal preference [16]. A. caviae was 
the predominating species in most studies, followed by A. 
hydrophila and A. veronii biovar. sobria [6, 12, 13, 16, 17]. 
A. hydrophila predominated in Brazil [18] and Thailand 
[19]; in Bangladesh, it was initially A. caviae [20] but later A. 
trota [21] (it should be kept in mind that later studies used 
more advanced methods of identification and differentia-
tion). In Finnish residents traveling in Morocco, A. veronii 
biovar. sobria came in first [22]. While some studies did 
find significant differences in the frequency of aeromonads 
isolated from diarrhoic patients including travelers [22] as 
opposed to controls [12, 14–16], others did not [17, 23, 24]. 
One study found differences in children – more prone to di-
arrhea anyway – but not in adults [25]. In Thailand, the dif-
ference was significant for Peace Corps volunteers but not 
for indigenous people [19]. The average isolation rate from 
diarrhoic stools was 0.8 to 7.4%; in healthy controls, it was 
0.4 to 2.1% [26]. Individual studies, however, vary widely 
in this regard, e.g., a study of infants in Peru found 52.4% 
in diarrhoic patients vs 8.7% in controls [12]. Of note, if 
the concomitant enteropathogens were removed from the 
statistics and isolates were speciated, the significant dif-
ference between patients and controls would disappear in 
this study. The frequency of copathogens was also high in 
India and Bangladesh (ci. 40%; 10,14) and in Chile (50%, 
23). Control groups showed frequencies of 0 to 2.1% in 
Western Europe and the USA [15, 17, 25] and higher ones 
in warmer climates (4.8% in Bangladesh, 5.2% in Chile) 
[14, 23]; in Peru, they ranged from 0 to 21.4% [12]. The car-
rier state was transient [16], sometimes involving multiple 
phenotypes [10, 13, 27]. Ranking of individual species was 
generally equal in patients and controls [12, 17]. Finally, a 
quantitative study showed considerable variations in the 
number of colony-forming units (CFU) of aeromonads 
during different sampling periods, and CFU overlapped 
between patients (3.5 to 9.9 log10 CFU/gm stool) and con-
trols (5.7 to 6.0 log10 CFU/gm) [11]. In another study, the 
amount of growth on a selective (Monsur agar) plate was 
not associated with the presentation of diarrhea [6].
Symptomatology
Symptoms of A.-a.d. were quite variable. Stool consistency 
varied from loose to watery to bloody; and diarrhea was 
either self-limited , lasting up to one week, or took a pro-
longed course of up to two weeks, or became “chronic” 
with more than one month duration [11, 13, 15]. Nausea, 
abdominal cramps, fever, and vomiting were observed only 
in part of the patients [11, 13]. In one study, duration was 
longer and fever more prominent with A. caviae than with 
A. hydrophila or A. veronii biovar sobria [13]. While in the 
majority of patients the small intestine seemed to be af-
fected only, up to one-third showed colitis by endoscopy 
[11, 28, 29]. A few cases of hemolytic-uremic syndrome 
(HUS) following A.-a.d. [2, 30, 31] but no cases of reactive 
arthritis have been reported.
Similar to some cases of bacterial gastroenteritis, low 
stomach acidity, liver and gastrointestinal disease as well 
as recent therapy with antimicrobials ineffective against 
aeromonads have been reported as associated factors [11, 
13, 32]. AIDS patients, however, did not show a higher fre-
quency of A.-a.d. than non-AIDS patients [33].
Cessation of diarrhea following therapy with antimi-
crobials effective against aeromonads has been reported 
[11] but its significance for a causation of diarrhea remains 
questionable in view of the frequently self-limited course 
of A.-a.d. More significant would be the disappearance of 
diarrhea or of colonic lesions together with newly nega-
tive stool cultures, as has been reported for single cases 
[11, 28, 29, 34]. This could, of course, also be due to a 
self-limited disease or to a transient state of colonization 
with aeromonad(s) [16, 27] in the presence of other en-
teropathogens. Unfortunately, follow-up typing of carrier 
isolates has never been done.
Common-Source Outbreaks and Transmission 
of Fecal Isolates
Although outbreaks are well known for enteropathogenic 
bacteria, the evidence for outbreaks with aeromonads is 
almost non-existent in spite of their ubiquitous occurrence 
in water sources like drinking water [9] and in foods such 
as seafood, meat, and vegetables [35].
The first outbreaks of A.-a.d. were reported from two 
day care centers where 6 of 25 and 5 of 24 diarrhoic chil-
dren, respectively, yielded fecal Aeromonas strains [36]. 
However, the PFGE patterns differed in all except two 
strains. Of 17 diarrhoic patients from Wisconsin whose 
stools contained aeromonads, 14 had their drinking water 
examined for these organisms; only one source was positive. 
Additional isolates from private wells were unrelated by 
PFGE to patient isolates [9]. A similar result was obtained 
in another study using ribotyping [37]. Conversely, during 
a 68-week observation period in Melbourne in which 795 
stool samples from diarrhoic patients were examined, none 
yielded aeromonads but half of the drinking water samples 
of the patients, drawn weekly, yielded the organisms [38]. 
In another study from Wisconsin, A.-a.d. was more often 
associated with consumption of aeromonad-free drink-
ing water than with consumption of untreated water [39]. 
Seemingly in contradiction was a study associating A.-a.d. 
with drinking untreated water but that water had not been 
examined for aeromonads [32].
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Two tropical outbreaks have been reported. In one [40], 
28 of 69 patients admitted during one month to a Beng-
hazi, Libya, hospital had “A. sobria” isolated from their 
stools. A source could not be found. The biochemical char-
acteristics suggested A. hydrophila but the identification 
was questionable because the strains produced hydrogen 
sulfide. In the other report [41], six children in a hematol-
ogy-oncology unit in Chandigarh, India, developed acute 
A.-a.d. with “A.sobria” during a four-week period. All iso-
lates had similar biotypes and antibiograms. Since neither 
study had used controls or molecular typing they cannot be 
used as proof for the presence of an outbreak.
That molecular methods are crucial in this connection was 
also shown in cases where transmission might have occurred 
from food, the environment or from patient(s) to patient(s). 
In one suggestive case of transmission from egg salad, no typ-
ing had been done [42]. In a further study mentioned previ-
ously [31], several isolates of “A. sobria” were cultured from 
an aquarium with which an infant had contact. The infant 
developed A.-a.d. and HUS . While all A. sobria isolates pro-
duced aerolysin (see below) and the diarrhea disappeared 
with the disappearance of A. sobria from the stool, the iso-
lates from the aquarium and from the stool were not identi-
cal in their nucleotide sequences (in view of the multiplicity 
of environmental types it may, however, have been possible 
that not enough colonies had been checked). In this connec-
tion, it is of interest that studies on Aeromonas strains from 
patients` environments have revealed that identical ribotypes 
may be found in epidemiologically related, but also in unre-
lated strains [43]. In one instance, A. caviae was isolated from 
three children, from their mother, and from well water used 
by them. Ribotyping showed identical types in the children 
but unique patterns in the mother and in the well water [44]. 
Cultures of Aeromonas strains in India obtained during a two-
year period have shown multiple types, virulence genes, and 
antibiograms [10].
Only two studies have found identical ribotypes to sug-
gest transmission, one from food (shrimp) to a patient with 
A.-a.d. [45] , and another one from a child to her foster 
parents [44]. The outbreak of food poisoning with diarrhea 
after consumption of Swedish “landgang”, however, from 
which 6 to 7 log10 CFU/gm of enterotoxin-producing A. 
hydrophila was isolated, lacked stool cultures to prove the 
causative agent [46].
Experimental Infections
Surprising for an allegedly enteropathogenic organism, oral 
challenge of 57 human volunteers with 5 different A. hy-
drophila strains producing cytotoxin and cholera toxin-re-
active factor (presumably Act) as well as “hemolysin” (see 
below), using 4 to 10 log10 CFU, led only to mild/moderate 
diarrhea in two participants who received 7 and 9 log10 
CFU, respectively. 55 remained unaffected, although most 
became colonized [47]. Likewise, oral challenge of protein-
malnourished mice [48] or of mice pretreated with strep-
tomycin [49] or clindamycin [50] led to colonization only. 
In the highly artificial RITARD (removable intestinal tie 
adult rabbit diarrhea) model [51] using 12 isolates of three 
Aeromonas species from A.-a.d. patients and from carri-
ers diarrhea, bacteremia, and death were strain-dependent. 
Diarrhea was seen in 23 of 37 rabbits who died and in 11 of 
27 who survived (p = 0.15). Bacteremia was found in 36 of 
the moribund ones and in 2 of the survivors. Colonization 
was detected in all animals but, as in studies mentioned 
previously [16, 27], lasted only up to 10 days. The ileum was 
the most heavily colonized part of the intestine.
Host Response
Similar to other diarrheas in which the causative agent is 
found in the intestine only, serum assays for antibody re-
sponses in A.-a.d. have shown insufficient sensitivity and 
specificity. 7 of 10 sera from patients with A.-a.d. showed 
no agglutinating antibodies; 5 of these 7 had titers of 1:16 
to 1:64 by passive hemagglutination, but that was similar 
to controls [32]. An ELISA for IgM and IgG responses to 
the lipopolysaccharides (LPS) of homologous strains had 
a sensitivity of 30% and a specificity (vs healthy blood do-
nors) of 74% [52]. A cytotoxin-neutralizing assay had a 
46% sensitivity and a 94% specificity; only patients with se-
vere acute diarrhea over 60 years of age reacted positively 
[52]. In a case of HUS following A.-a.d., these neutralizing 
antibodies showed rising titers [30]. SIgA responses to fe-
cal extracts of 13 patients with A.-a.d. showed fourfold or 
more titer increases in 11 by dot-blot and in 8 by Western 
blot but were limited to A. hydrophila and “A. sobria”; two 
patients with A. caviae did not react [53]. If extracellular 
products similar to hemolytic toxins were used, specific 
sIgA responses were seen in 11 of 13 extracts from patients 
with A.-a.d [54]. Neither study had examined carriers or 
blood donors.
Virulence Factors: Occurrence
Aeromonads may produce a variety of biologically ac-
tive extracellular substances similar to virulence factors 
known in other enteropathogenic bacteria. They include 
fimbriae, flagella, outer membrane proteins, an S layer, li-
polpolysaccharides (endotoxin), capsules, proteases, glyc-
erophospholipid:cholesterol acyl transferase (GCAT), and 
siderophores (amonabactin, enterobactin) [26, 55]. Their 
relationship to enteropathogenicity has not been eluci-
dated except that type IV pili have been reported to be 
associated with gastroenteritis [56].
Toxins of particular interest for gastrointestinal 
infections, i.e., enterotoxins, are also present in aero-
monads [26, 55] and were found to be chromosomally 
encoded [57]. All cause fluid secretion in rabbit ileal 
loops. They include:
–  the cytotoxic, heat-labile (56 °C, 20 min) type II-se-
creted enterotoxin Act which is also hemolytic and 
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destroys the intestinal epithelium via cytokines and 
activation of the arachidonic acid metabolism;
–  two (the heat-labile Alt and the heat-stable Ast ) cyto-
tonic enterotoxins which cause an increase in intracel-
lular cAMP and prostaglandins and elongate Chinese 
hamster overy (CHO) cells;
–  various hemolysins, among them AerA , HlyA, Ahh1, 
Asa1[59, 60], and the “A. sobria” hemolysin [61] which 
increases intracellular cAMP. It should be emphasized 
that hemolysis on blood agar plates used in the clini-
cal laboratories is not a reliable indicator of hemolysin 
production since it depends on other factors such as the 
animal source of the erythrocytes and, in experimental 
models, the number of passages in ileal loops [51, 62, 
63]. Generally, erythrocytes are hemolyzed on sheep 
blood agar plates by A. hydrophila and A. veronii bi-
ovar. sobria but rarely by A. caviae.
Here again, studies have found the cytotoxin more fre-
quently in Aeromonas isolates from diarrhoic patients than 
from carriers [64] while in Brazil, the heat-stable cytotonic 
toxin, the cytotoxin and adhesins were not more frequent in 
diarrhoic patients than in controls [18]. Others found them 
more frequently in isolates of A. hydrophila than in those of 
A. caviae and A. veronii biovar. sobria but not more often in 
diarrhoic than in carrier or environmental strains [23]. The 
presence of various hemolysins did not show any relation-
ship to the occurrence of diarrhea in one study [6].
Fecal, extraintestinal, and environmental strains of A. 
hydrophila, A. caviae, and A. veronii biovar. sobria were 
recently found to have a type III secretion system [65].
Virulence Factors: Genetic Analysis
In a study of Bangladeshi children [21], DNA probes were 
used for identification of the genes for the enterotoxins. 
Act was never found alone, and only in the species A. hy-
drophila together with the other two genes. Diarrhoic chil-
dren yielded significantly higher numbers of isolates car-
rying alt plus ast than carriers and environmental samples 
but yielded lower numbers of isolates than environmental 
strains that carried ast only. For isolates with alt alone and 
for different Aeromonas species, significant differences in 
the frequency of these genes between the three types of 
samples could not be detected. The presence of alt plus ast 
was associated with watery stools whereas alt alone was as-
sociated with loose stools. It was concluded that alt plus ast 
may synergistically lead to more severe diarrhea, whereas 
act was found associated with bloody diarrhea [21]. In the 
Indian study [10], only diarrhoic isolates were investigated 
and yielded a similar distribution as in [21] for alt between 
the species but not for act and ast. Transposon mutants of 
an A.-a.d. isolate of A. hydrophila which affected the tran-
scription of act resulted in reduced virulence by 2 log10 in 
mice when injected intraperitoneally. Culture filtrates of 
isogenic mutants with a truncated act caused no damage to 
the microvilli, did not show hemolytic activity any more, 
and showed reduced mouse virulence by 3 log10. Reinte-
gration of the native act resulted in complete restoration 
of its former activity [67]. Knockout mutants caused by 
marker-exchange mutagenesis showed reductions in fluid 
secretions in ileal loops by 64, 48, and 43% in mutants af-
fecting act, alt, and ast, respectively [66].
Double knockout mutants showed reductions of 36, 62, 
and 73% in alt plus ast, act plus ast, and act plus alt, respec-
tively. A triple knockout mutant failed to elicit fluid secre-
tion. The greatest damage, thus, seemed to come from act, 
followed by alt and ast [67].
Genes for hemolysis were found in a majority of A. hy-
drophila and A. veronii biovar. sobria, but not of A. caviae, 
from diarrhoic patients [6, 60]. The absence of hly and 
aer has led to a 20-fold reduction in the LD 50 in a suck-
ling mouse model [61]. Deletion of the gene encoding the 
Aeromonas OMP which is a structural component of the 
type III secretion system resulted in a significant reduction 
in inflammatory cytokines and chemokines in the sera of 
infected mice [68].
Conclusions
At this time, it seems as if only certain infraspecific sub-
sets of aeromonads provided with certain genes for en-
terotoxicity are significantly associated with diarrhea, 
the best evidence arising from genetic analysis. Falkow
,
s 
proposed “molecular Koch Postulates” [69] would 
almost have been fulfilled, depending on the interpre-
tation of the first postulate. Unfortunately, this will be 
of little help to the clinical microbiologist and to public 
health personnel. The microbiologist may, however, base 
his judgment upon the obvious rarity of person-to-per-
son transmission, the lack of proven outbreaks and of 
experimental pathogenicity for man, and the frequently 
self-limited character of A.-a.d. At the present time, 
he may, therefore, decide to limit the search for aeromon-
ads in stools to those from patients with chronic diarrhea 
for which no other cause can be found. The epidemiologist 
will, however, insist on isolation and species identification, 
if not typing. The fact that recovery of aeromonads from 
water did not correlate with recovery from stool suggests 
caution in recommending public health measures to control 
aeromonads in water.
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